University Medical Center Hamburg-Eppendorf
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University Medical Center Hamburg-Eppendorf
Pharmaxon aims to control cell mobility to fight disorders of the central nervous system and cancer. For glioblastoma, it has developed a neural cell mobility inhibitor that blocks cell migration in vitro and limits glioblastoma proliferation in animal models.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.